EIF4A3 and bladder transitional cell carcinoma: Furthermore, the specific mechanisms of how EIF4A3 regulates apoptosis and reshapes the immune microenvironment in BLCA in vitro and in vivo, and the impact of specific EIF4A3 inhibitors on the efficacy of immunotherapy need to be further investigated in depth.